ARKK vs AVDL
ARK Innovation ETF (ARKK) versus Avadel Pharmaceuticals PLC (AVDL) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
ARKK currently screens at market cap $0. AVDL currently screens at market cap $968.5M.
Not investment advice. Open the ARKK and AVDL stock pages for the full models.
Not investment advice.